Initial clinical trials with kisspeptin demonstrate potential to enhance implantation and pregnancy rates, while kisspeptin measurement can assist in evaluating reproductive health
Side-by-Side Reference Attribute Class SLU-PP-332 Synthetic small-molecule pan-ERR agonist MOTS-c Mitochondrial-derived peptide (16 aa) AOD-9604 Modified GH fragment (aa 176-191) Attribute Primary target SLU-PP-332 ERR / / nuclear receptors MOTS-c AMPK activation and mitochondrial signaling AOD-9604 Lipolysis pathways without GH-receptor signaling Attribute Half-life SLU-PP-332 Not formally published
Amino Asylum ignored them
WOLVERINE STACK (BPC-157 + TB-500) Rapid tissue, tendon, and muscle repair Reduces inflammation and pain Ideal for injuries or post-procedure recovery GLOW STACK (GHK-Cu + BPC-157 + TB-500) Regenerates skin, reduces wrinkles Promotes hair growth and elasticity Supports healing and inflammation control BPC-157 (Body Protective Compound) Heals gut lining, joints, and soft tissues Decreases pain and inflammation Ideal for IBS, leaky gut, or injuries TB-500 (Thymosin Beta 4) Enhances muscle recovery and flexibility Supports connective tissue healing Often used with BPC-157 CJC-1295 + Ipamorelin Stimulates natural growth hormone Promotes fat loss and muscle gain Improves sleep and recovery TESAMORELIN Reduces visceral (belly) fat Enhances muscle tone Originally FDA-approved for HIV-related lipodystrophy CJC-1295 + Ipamorelin Boosts natural growth hormone production Increases lean body mass Slows signs of aging and improves sleep AOD-9604 (Advanced Obesity Drug) Stimulates fat breakdown Supports weight loss without affecting blood sugar Ideal for body contouring support MOTS-c Mitochondrial peptide for cellular energy Enhances metabolism and insulin sensitivity Promotes longevity and endurance Nurse Practitioner Ina LaRocca is my health care and aesthetic skin care provider
Well help restore your eye health with a personalized treatment plan that is right for you
The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knockout mice
